Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Licitra

Showing results (41-50 of 101) with videos related to

Pageof 11
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 14, 2018
Tailoring treatment of salivary duct carcinoma (SDC) by liquid biopsy: ARv7 expression in circulating tumor cellsV Cappelletti, P Miodini, C Reduzzi, et al.
International Journal of Cancer|December 8, 1998
Biological markers as indicators of pathological response to primary chemotherapy in oral-cavity cancersA Costa, L Licitra, S Veneroni, et al.
Immuno-Oncology Technology|January 22, 2026
Adjuvant anti-PD-1 therapy in high-risk cutaneous squamous-cell carcinoma: <i>post hoc</i> insights from the C-POST and KEYNOTE-630 studiesS Cavalieri, A Ottini, C Bergamini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 2014
Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trialJ B Vermorken, A Psyrri, R Mesía, et al.
Critical Reviews in Oncology/Hematology|December 30, 2015
Pain management in head and neck cancer patients undergoing chemo-radiotherapy: Clinical practical recommendationsA Mirabile, M Airoldi, C Ripamonti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 27, 2016
Best practice guidelines in the psychosocial management of HPV-related head and neck cancer: recommendations from the European Head and Neck Cancer Society's Make Sense CampaignM Reich, L Licitra, J B Vermorken, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 23, 2011
Adding docetaxel to cisplatin and fluorouracil in patients with unresectable head and neck cancer: a cost-utility analysisN L Liberato, C Rognoni, S Rubrichi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2014
Best practices in the management of the psycho-oncologic aspects of head and neck cancer patients: recommendations from the European Head and Neck Cancer Society Make Sense CampaignM Reich, C R Leemans, J B Vermorken, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|September 16, 2017
Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patientsC Resteghini, S Cavalieri, D Galbiati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 22, 2012
Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-upA T C Chan, V Grégoire, J-L Lefebvre, et al.
Pageof 11

Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 14, 2018
Tailoring treatment of salivary duct carcinoma (SDC) by liquid biopsy: ARv7 expression in circulating tumor cellsV Cappelletti, P Miodini, C Reduzzi, et al.
International Journal of Cancer|December 8, 1998
Biological markers as indicators of pathological response to primary chemotherapy in oral-cavity cancersA Costa, L Licitra, S Veneroni, et al.
Immuno-Oncology Technology|January 22, 2026
Adjuvant anti-PD-1 therapy in high-risk cutaneous squamous-cell carcinoma: <i>post hoc</i> insights from the C-POST and KEYNOTE-630 studiesS Cavalieri, A Ottini, C Bergamini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 2014
Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trialJ B Vermorken, A Psyrri, R Mesía, et al.
Critical Reviews in Oncology/Hematology|December 30, 2015
Pain management in head and neck cancer patients undergoing chemo-radiotherapy: Clinical practical recommendationsA Mirabile, M Airoldi, C Ripamonti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 27, 2016
Best practice guidelines in the psychosocial management of HPV-related head and neck cancer: recommendations from the European Head and Neck Cancer Society's Make Sense CampaignM Reich, L Licitra, J B Vermorken, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 23, 2011
Adding docetaxel to cisplatin and fluorouracil in patients with unresectable head and neck cancer: a cost-utility analysisN L Liberato, C Rognoni, S Rubrichi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2014
Best practices in the management of the psycho-oncologic aspects of head and neck cancer patients: recommendations from the European Head and Neck Cancer Society Make Sense CampaignM Reich, C R Leemans, J B Vermorken, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|September 16, 2017
Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patientsC Resteghini, S Cavalieri, D Galbiati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 22, 2012
Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-upA T C Chan, V Grégoire, J-L Lefebvre, et al.
Pageof 11